Drugs / pottasium phosphate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02746432 Background | Jan 2018 → Mar 2021 | colon carcinoma | King Saud University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pottasium phosphate | “an Infusion of dextrose 20% supplemented with pottasium phosphate (30 mmol/L ) to be administered.” NCT02746432 ↗ |